INDV vs. HCM, HIK, GNS, SPI, ONT, CRW, UPR, PRTC, CTEC, and BMK
Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include HUTCHMED (HCM), Hikma Pharmaceuticals (HIK), Genus (GNS), Spire Healthcare Group (SPI), Oxford Nanopore Technologies (ONT), Craneware (CRW), Uniphar (UPR), PureTech Health (PRTC), ConvaTec Group (CTEC), and Benchmark (BMK). These companies are all part of the "medical" sector.
HUTCHMED (LON:HCM) and Indivior (LON:INDV) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk.
HUTCHMED has higher earnings, but lower revenue than Indivior. HUTCHMED is trading at a lower price-to-earnings ratio than Indivior, indicating that it is currently the more affordable of the two stocks.
Indivior received 360 more outperform votes than HUTCHMED when rated by MarketBeat users. Likewise, 80.35% of users gave Indivior an outperform vote while only 78.40% of users gave HUTCHMED an outperform vote.
HUTCHMED has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Indivior has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500.
Indivior has a consensus target price of GBX 2,515, suggesting a potential upside of 78.62%. Given HUTCHMED's higher possible upside, analysts plainly believe Indivior is more favorable than HUTCHMED.
HUTCHMED has a net margin of 12.03% compared to HUTCHMED's net margin of 0.18%. Indivior's return on equity of 14.65% beat HUTCHMED's return on equity.
In the previous week, Indivior had 1 more articles in the media than HUTCHMED. MarketBeat recorded 3 mentions for Indivior and 2 mentions for HUTCHMED. Indivior's average media sentiment score of 0.60 beat HUTCHMED's score of 0.28 indicating that HUTCHMED is being referred to more favorably in the media.
32.3% of HUTCHMED shares are held by institutional investors. Comparatively, 92.9% of Indivior shares are held by institutional investors. 42.9% of HUTCHMED shares are held by insiders. Comparatively, 3.2% of Indivior shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Indivior beats HUTCHMED on 9 of the 17 factors compared between the two stocks.
Get Indivior News Delivered to You Automatically
Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INDV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Indivior Competitors List
Related Companies and Tools
